Jean M. Connors MDHematology Attending, Medical Director, Hemostatic Antithrombotic Stewardship and Anticoagulation Management Services, Brigham and Women’s Hospital; Associate Professor, Harvard Medical School, Boston, Massachusetts
Jean M. Connors, MD, is a hematology attending at Brigham and Women’s Hospital and Dana Farber Cancer Institute, the Medical Director of the inpatient Hemostatic Antithrombotic Stewardship program and the outpatient Anticoagulation Management Services, and an associate professor of medicine at Harvard Medical School. She attended Johns Hopkins School of Medicine, did medical residency at Beth Israel Hospital Boston, and completed fellowship training in hematology-oncology at Brigham and Women’s Hospital and in transfusion medicine at the Harvard Joint Program in Transfusion Medicine. She works closely with the Hemostatic Antithrombotic Stewardship staff responsible for oversight and management of anticoagulants and hemostatic agents across all inpatient services at BWH. Dr. Connors has participated in numerous clinical trials for patients with venous thrombosis and for the use of reversal agents for the direct oral anticoagulants, and is a leading investigator in trials in the area of mechanical circulatory support and cancer associated thrombosis.
Recent Contributions to PracticeUpdate:
- Association of Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
- Rivaroxaban vs Vitamin K Antagonist in Antiphospholipid Syndrome
- Andexanet Alfa Reduces Anti-Factor Xa Activity by Factor Xa Inhibitors
- Fibrinogen Concentrate Supplementation After Complex Cardiac Surgery